Skip to content

Topaz Biosciences

3 viewers · 30d

Total raised

$1.4M

1 filing since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $1.4M
ROUNDS
1
INVESTORS
8
FOUNDED
2022
HQ
Emeryville, CA
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
3

AI overview

Updated

Topaz Biosciences, Inc. is a biotechnology company that specializes in developing innovative solutions for skin health, with a strong emphasis on harnessing the potential of the skin microbiome. Established in 2022 and based in Emeryville, California, the company is committed to addressing common skin issues such as eczema and acne through scientifically-backed enzyme technology.

What sets it apart

Topaz Biosciences stands out due to its proprietary metagenomics platform, which allows for the discovery of novel enzyme activities that cannot be replicated through conventional methods.

Funding history

1 round
EquityMar 11, 2025
Form D
+$1.4M$1.4M total

Latest SEC filings

via EDGAR · CIK 0002062605
Form D · Mar 11, 2025View on EDGAR

Products

1 tracked

Enzyme Technology for Skin Health

Skin Care

Topaz Biosciences offers a cutting-edge enzyme technology that targets and selectively reduces harmful bacteria on the skin while preserving beneficial strains. This innovative approach is designed to rebalance the skin microbiome, making it particularly effective for individuals suffering from eczema and acne.

  • Selective reduction of harmful bacteria
  • Preservation of beneficial skin microorganisms
  • Clinically proven efficacy for skin conditions
  • Formulatable into various skincare products

Links

WebsiteSEC EDGAR filings